25 - 27 November – Cologne, Germany

Axiogenesis Application Workshop
Great Assays for iPSC-Derived Neurons & Cardiomyocytes

Meet the Axiogenesis team and collaboration partner

Axiogenesis Sublicenses GE Healthcare iPSC Patents

Axiogenesis AG has sublicensed patents from GE Healthcare to commercialize technologies based on human induced pluripotent stem cells (iPSCs). This solidifies the ability for Axiogenesis and its customers to apply Axiogenesis cell types in the development of cellular assays and stem cell-derived disease models for use in drug discovery and toxicity screening. For the complete press release, click here.

New Axiogenesis Web Site Launched

For the last couple of months, we worked behind the scenes on our new website. Today, we are proud to present to you our new face and welcome you to the Axiogenesis website! The new design enables us to present our growing portfolio and new products clearly arranged. 

Continue Reading

iPSC Neuronal Applications Workshop 2015: Documents Available for Download

The Annual iPSC Neuronal Applications Workshop 2015 was held at the 15th - 17th of April in Cologne at the Axiogenesis headquarters. We thank our 50 attendees, cooperation partners and presenters for their great contribution!

Focusing on our neuronal products Dopa.4UTM and Peri.4UTM, during the symposium data were presented on different assays as dendrite outgrowth (imaging, impedance), Parkinson’s disease model (imaging), toxicology (Multi Electrode Assay), action potential measurement and postsynaptic currents (Patch Clamp).

Continue Reading


Nattermannallee 1, Bldg S20
50829 Cologne
Germany – (Map)

600 W Germantown Pike, Suite 110
Plymouth Meeting, PA 19462
USA – (Map)


Orders: order@axiogenesis.com
Support: support@axiogenesis.com
Other: office@axiogenesis.com


Twitter:   |   LinkedIn:   |   Newsletter: Subscribe Axiogenesis Newsletter


Phone (Main)
+49 221 99 88 18-0

Phone (US)
+1 844-511-6959

Fax + 49 221 99 88 18-10